Medicare and Medicaid would cover weight-loss drugs like Wegovy and Ozempic under a new rule proposed by President Joe Biden on Tuesday, increasing access to the widely popular medications to millions of adults with obesity in the U.S., though the plan would likely face opposition under President-elect Donald Trump's second administration.

Trump’s pick to run Medicare and Medicaid is involved with a number of businesses that are involved with both.

Mehmet Oz’s conflicts of interest may jeopardize the federal budget if approved as administrator of the Centers for Medicare and Medicaid Services administrator. Health reporter Lauren Weber explains.